You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
regulatory guidance autism
About this tag
This tag covers discussions on regulatory guidance related to autism, including official positions from medical societies. A recent thread highlights South African medical societies rejecting claims that paracetamol use during pregnancy causes autism, aligning with international health authorities. The content focuses on how regulatory bodies evaluate scientific evidence and issue guidance on autism risk factors. Topics include prenatal medication safety, autism spectrum disorder research, and the role of health organizations in communicating evidence-based recommendations. The tag is relevant for users seeking authoritative perspectives on autism-related regulatory stances and public health advisories.
South African medical societies have strongly rejected recent claims that taking paracetamol during pregnancy causes autism in children, placing themselves firmly in line with international health authorities who say the available science does not support a causal link. Background
The...